Xenon Pharmaceuticals IncNASDAQ:XENE
- LAST PRICE40.4200
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots35.0000/ 1
- Ask / Lots40.9900/ 2
- Open / Previous Close0.0000 / 40.4200
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | XENE |
|---|---|---|
| 09:32 ET | 4982 | 39.7 |
| 09:36 ET | 300 | 39.56 |
| 09:41 ET | 100 | 39.54 |
| 09:43 ET | 16100 | 39.47 |
| 09:45 ET | 10200 | 39.655 |
| 09:50 ET | 2300 | 39.38 |
| 09:52 ET | 4900 | 39.475 |
| 09:54 ET | 500 | 39.455 |
| 09:56 ET | 1600 | 39.31 |
| 09:57 ET | 129 | 39.455 |
| 09:59 ET | 534 | 39.455 |
| 10:06 ET | 5400 | 39.365 |
| 10:10 ET | 400 | 39.35 |
| 10:12 ET | 12668 | 39.19 |
| 10:14 ET | 100 | 39.28 |
| 10:17 ET | 682 | 39.18 |
| 10:21 ET | 1600 | 39.24 |
| 10:24 ET | 100 | 39.31 |
| 10:26 ET | 140 | 39.4 |
| 10:30 ET | 200 | 39.345 |
| 10:32 ET | 200 | 39.305 |
| 10:33 ET | 100 | 39.305 |
| 10:35 ET | 100 | 39.26 |
| 10:37 ET | 7269 | 39.2701 |
| 10:39 ET | 1100 | 39.325 |
| 10:42 ET | 5508 | 39.325 |
| 10:44 ET | 3273 | 39.415 |
| 10:48 ET | 6100 | 39.44 |
| 10:53 ET | 600 | 39.48 |
| 10:55 ET | 1026 | 39.34 |
| 10:57 ET | 100 | 39.38 |
| 11:04 ET | 4700 | 39.41 |
| 11:06 ET | 100 | 39.39 |
| 11:09 ET | 355 | 39.35 |
| 11:11 ET | 1574 | 39.33 |
| 11:13 ET | 600 | 39.3 |
| 11:18 ET | 4000 | 39.275 |
| 11:20 ET | 600 | 39.22 |
| 11:22 ET | 500 | 39.3 |
| 11:24 ET | 700 | 39.32 |
| 11:26 ET | 2204 | 39.31 |
| 11:29 ET | 2618 | 39.48 |
| 11:31 ET | 494 | 39.51 |
| 11:36 ET | 108 | 39.47 |
| 11:40 ET | 403 | 39.525 |
| 11:42 ET | 308 | 39.48 |
| 11:45 ET | 200 | 39.525 |
| 11:47 ET | 100 | 39.56 |
| 11:51 ET | 1300 | 39.51 |
| 11:54 ET | 200 | 39.5 |
| 11:56 ET | 200 | 39.48 |
| 12:00 ET | 286 | 39.49 |
| 12:03 ET | 1638 | 39.4 |
| 12:07 ET | 100 | 39.49 |
| 12:12 ET | 3880 | 39.56 |
| 12:14 ET | 300 | 39.53 |
| 12:16 ET | 300 | 39.55 |
| 12:18 ET | 603 | 39.56 |
| 12:20 ET | 100 | 39.57 |
| 12:21 ET | 500 | 39.53 |
| 12:23 ET | 100 | 39.5 |
| 12:25 ET | 100 | 39.56 |
| 12:27 ET | 400 | 39.575 |
| 12:30 ET | 1900 | 39.565 |
| 12:32 ET | 3734 | 39.715 |
| 12:36 ET | 3223 | 39.69 |
| 12:38 ET | 1598 | 39.705 |
| 12:41 ET | 604 | 39.817 |
| 12:43 ET | 500 | 39.75 |
| 12:45 ET | 450 | 39.79 |
| 12:48 ET | 1400 | 39.74 |
| 12:50 ET | 500 | 39.67 |
| 12:56 ET | 200 | 39.76 |
| 12:59 ET | 100 | 39.76 |
| 01:01 ET | 300 | 39.76 |
| 01:03 ET | 100 | 39.73 |
| 01:06 ET | 4200 | 39.76 |
| 01:08 ET | 400 | 39.725 |
| 01:12 ET | 100 | 39.77 |
| 01:15 ET | 2742 | 39.73 |
| 01:17 ET | 598 | 39.735 |
| 01:19 ET | 443 | 39.68 |
| 01:24 ET | 300 | 39.75 |
| 01:26 ET | 326 | 39.75 |
| 01:28 ET | 689 | 39.72 |
| 01:32 ET | 300 | 39.7 |
| 01:33 ET | 253 | 39.68 |
| 01:35 ET | 62715 | 39.71 |
| 01:37 ET | 13715 | 39.83 |
| 01:39 ET | 300 | 39.84 |
| 01:42 ET | 300 | 39.86 |
| 01:44 ET | 935 | 39.83 |
| 01:50 ET | 9622 | 39.935 |
| 01:53 ET | 300 | 39.95 |
| 01:55 ET | 2310 | 39.955 |
| 01:57 ET | 1000 | 39.955 |
| 02:00 ET | 100 | 40.11 |
| 02:02 ET | 3086 | 40.01 |
| 02:04 ET | 300 | 39.995 |
| 02:09 ET | 100 | 40.01 |
| 02:13 ET | 200 | 40.0825 |
| 02:15 ET | 200 | 40.125 |
| 02:18 ET | 752 | 40.15 |
| 02:20 ET | 1524 | 40.18 |
| 02:24 ET | 600 | 40.16 |
| 02:29 ET | 800 | 40.09 |
| 02:31 ET | 700 | 40.05 |
| 02:33 ET | 200 | 40.075 |
| 02:36 ET | 11448 | 39.945 |
| 02:38 ET | 1251 | 39.955 |
| 02:40 ET | 500 | 39.96 |
| 02:42 ET | 677 | 39.965 |
| 02:44 ET | 1318 | 39.92 |
| 02:45 ET | 300 | 39.96 |
| 02:47 ET | 400 | 40.07 |
| 02:49 ET | 339 | 40.06 |
| 02:54 ET | 210 | 40.13 |
| 02:56 ET | 100 | 40.03 |
| 02:58 ET | 600 | 40.05 |
| 03:00 ET | 100 | 40.125 |
| 03:02 ET | 1900 | 40.13 |
| 03:03 ET | 300 | 40.14 |
| 03:05 ET | 100 | 40.2 |
| 03:07 ET | 928 | 40.15 |
| 03:09 ET | 200 | 40.208 |
| 03:12 ET | 700 | 40.18 |
| 03:16 ET | 100 | 40.19 |
| 03:18 ET | 443 | 40.18 |
| 03:21 ET | 200 | 40.17 |
| 03:23 ET | 217 | 40.21 |
| 03:25 ET | 300 | 40.19 |
| 03:27 ET | 200 | 40.19 |
| 03:30 ET | 2390 | 40.15 |
| 03:32 ET | 800 | 40.08 |
| 03:34 ET | 200 | 40.04 |
| 03:36 ET | 624 | 40.03 |
| 03:38 ET | 100 | 40.03 |
| 03:39 ET | 900 | 40.02 |
| 03:41 ET | 100 | 39.995 |
| 03:43 ET | 900 | 40.08 |
| 03:45 ET | 2300 | 40.11 |
| 03:48 ET | 1200 | 40.07 |
| 03:50 ET | 1599 | 40.075 |
| 03:52 ET | 3904 | 39.95 |
| 03:54 ET | 2576 | 40.07 |
| 03:56 ET | 8836 | 40.36 |
| 03:57 ET | 5847 | 40.37 |
| 03:59 ET | 4911 | 40.42 |
May 10, 2024
DJ Xenon Pharmaceuticals Is Maintained at Buy by Needham, from 6:12PM ET on Friday May 10, 2024 by Dow Jones
6:12PM ET on Friday May 10, 2024 by Dow JonesDJ Xenon Pharmaceuticals Is Maintained at Buy by Citigroup, from 5:48PM ET on Friday May 10, 2024 by Dow Jones
5:48PM ET on Friday May 10, 2024 by Dow JonesDJ Xenon Pharmaceuticals Is Maintained at Outperform by Wedbush, from 9:30AM ET on Friday May 10, 2024 by Dow Jones
9:30AM ET on Friday May 10, 2024 by Dow Jones
May 9, 2024
Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update, from 4:01PM ET on Thursday May 09, 2024 by Dow Jones
4:01PM ET on Thursday May 09, 2024 by Dow Jones*DJ Xenon Pharmaceuticals 1Q Loss/Shr 62c >XENE, from 4:01PM ET on Thursday May 09, 2024 by Dow Jones
4:01PM ET on Thursday May 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Xenon Pharmaceuticals Inc | 3.1B | -14.9x | --- |
Apogee Therapeutics Inc | 3.1B | -25.6x | --- |
Dyne Therapeutics Inc | 3.1B | -8.9x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
SpringWorks Therapeutics Inc | 3.1B | -8.3x | --- |
Summit Therapeutics Inc | 3.2B | -27.4x | --- |
Company Information
Xenon Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company focused on developing therapeutics to improve the lives of patients with neurological disorders, with a focus on epilepsy. The Company’s product pipeline includes XEN1101 (Focal Onset Seizures), XEN1101 (Primary Generalized Tonic-Clonic Seizures), XEN1101 (Major Depressive Disorder) and NBI-921352 (NEUROCRINE). It is developing XEN1101, a differentiated Kv7 potassium channel opener, for the treatment of epilepsy, MDD and potentially other neurological disorders. Its XEN1101 Phase III epilepsy program includes two identical Phase III clinical trials, called X-TOLE2 and X-TOLE3, that are designed closely after the Phase IIb X-TOLE clinical trial. Its Phase III X-ACKT clinical trial is intended to support potential regulatory submissions in an additional epilepsy indication of primary generalized tonic-clonic seizures (PGTCS).
Contact Information
- Headquarters
- 3650 Gilmore WayVANCOUVER, BC, Canada V5G 4W8
- Phone
- 604-484-3300
- Fax
- 604-484-3450
Executives
- Chairman of the Board
- Simon Pimstone
- President, Chief Executive Officer, Director
- Ian Mortimer
- Chief Financial Officer
- Sherry Aulin
- Executive Vice President - Drug Discovery
- James Empfield
- Executive Vice President - Strategy and Innovation
- Robin Sherrington
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.1B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 75.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.23 |
EPS | $-2.71 |
Book Value | $12.31 |
P/E Ratio | -14.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
